Rocket Pharmaceuticals Inc (NASDAQ: RCKT) started the day on Wednesday, with a price increase of 7.96% at $3.39, before settling in for the price of $3.14 at the close. Taking a more long-term approach, RCKT posted a 52-week range of $2.19-$18.89.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -11.60%. Meanwhile, its Annual Earning per share during the time was -11.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.65%. This publicly-traded company’s shares outstanding now amounts to $107.88 million, simultaneously with a float of $98.63 million. The organization now has a market capitalization sitting at $365.80 million. At the time of writing, stock’s 50-day Moving Average stood at $3.20, while the 200-day Moving Average is $6.11.
Rocket Pharmaceuticals Inc (RCKT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Rocket Pharmaceuticals Inc’s current insider ownership accounts for 8.55%, in contrast to 85.83% institutional ownership. According to the most recent insider trade that took place on Aug 27 ’25, this organization’s Director bought 10,000 shares at the rate of 3.41, making the entire transaction reach 34,100 in total value, affecting insider ownership by 40,000. Preceding that transaction, on Aug 18 ’25, Company’s insider sold 699 for 3.06, making the whole transaction’s value amount to 2,142. This particular insider is now the holder of 56,285 in total.
Rocket Pharmaceuticals Inc (RCKT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
Rocket Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 24.65% and is forecasted to reach -1.19 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 20.15% through the next 5 years, which can be compared against the -11.60% growth it accomplished over the previous five years trading on the market.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Let’s observe the current performance indicators for Rocket Pharmaceuticals Inc (RCKT). It’s Quick Ratio in the last reported quarter now stands at 6.39.
In the same vein, RCKT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.50, a figure that is expected to reach -0.49 in the next quarter, and analysts are predicting that it will be -1.19 at the market close of one year from today.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
If we take a close look at the recent performances of Rocket Pharmaceuticals Inc (NASDAQ: RCKT), its last 5-days Average volume was 2.95 million that shows plunge from its year to date volume of 3.52 million. During the previous 9 days, stock’s Stochastic %D was recorded 29.84% While, its Average True Range was 61.58.
Raw Stochastic average of Rocket Pharmaceuticals Inc (RCKT) in the period of the previous 100 days is set at 25.56%, which indicates a major fall in contrast to 69.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.19 that was lower than 0.23 volatility it exhibited in the past 100-days period.
